放射線治療機器のインド市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2018年度～2032年度）

インドの放射線治療機器の市場規模は、2024年度の4億1,222万米ドルから2032年度に7億827万米ドルに達すると予測され、2025年度～2032年度にCAGRで7.00％の成長が見込まれます。市場は、がんの負担の増大、現地生産、技術の進歩、官民パートナーシップによって成長しています。

市場は、新規がん患者の増加、医療支出の増加、政府によるがん治療強化の取り組みにより拡大しています。好景気と中産階級人口の急増により、先進医療技術の採用に巨額の投資が行われています。さらに、強力な現地の能力による医療機器の生産における自給自足達成の動機は、輸入への依存を減らすことにあります。強力な官民パートナーシップにより、先進治療センターの設立が容易になっています。また、検診やがんの早期発見に対する意識の高まりも、放射線治療サービスへの需要の増加につながっています。世界の医療ハブとしての地位を築きたいという同国の熱望から、質の高いがん治療を提供し、国際市場で競争力をつけるために不可欠となる、先進の放射線治療機器を配備する必要性が生まれています。

さらに、がん専門センターや放射線治療施設などの医療センターが拡大することで、放射線治療機器の利用可能性やアクセス性が高まります。例えば2024年4月、ニューデリーにあるLady Hardinge Medical Collegeは、ブラキセラピー機器による初のがん患者の治療を開始しました。この治療は、一部のがんやその他の疾患の患者に提供されます。より多くの施設が設立されることで、放射線治療サービスへのアクセスが向上し、その結果、患者のさらなる治療における放射線治療機器の需要が増加します。

当レポートでは、インドの放射線治療機器市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの放射線治療装置市場の見通し（2018年度～2032年度）

• 市場規模の分析と予測
  • 金額
  • 数量
• 市場シェアの分析と予測
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 市場シェア分析：企業別（金額）（上位5社とその他 - 2024年度）
• 市場マップ分析（2024年度）
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 需給分析

第6章 輸入と輸出の分析

第7章 バリューチェーン分析

第8章 ポーターのファイブフォース分析

第9章 PESTLE分析

第10章 価格分析

第11章 市場力学

• 市場促進要因
• 市場の課題

第12章 市場の動向と発展

第13章 規制枠組みとイノベーション

• 規制当局の承認

第14章 特許情勢

第15章 ケーススタディ

第16章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位5社の情勢
  • Elekta Medical Systems India Pvt. Ltd.
  • Accuray Medical Equipment India Pvt. Ltd.
  • Koninklijke Philips N.V.
  • Ion Beam Applications S.A.
  • Vision RT Ltd.
  • BEBIG Medical GmbH
  • Mitsubishi Electric India Pvt. Ltd.
  • Varian Medical Systems, Inc.
  • Society for Applied Microwave Electronics Engineering & Research
  • Brainlab India Pvt. Ltd.

第17章 戦略的推奨

第18章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Radiotherapy Devices Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Radiotherapy Devices Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Radiotherapy Devices Market Share (%), By Product, FY2018-FY2032F
• Figure 4. India Radiotherapy Devices Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Radiotherapy Devices Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Radiotherapy Devices Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024

India radiotherapy devices market is projected to grow at a CAGR of 7.00% from FY2025 to FY2032, increasing from USD 412.22 million in FY2024 to USD 708.27 million by FY2032. The market for radiotherapy devices in India is growing due to an increase in the cancer burden, indigenous manufacturing, technological advancements, and public-private partnerships.

The Indian radiotherapy devices market is expanding as new cancer cases are growing, healthcare expenditure is rising, and the government is taking initiatives to enhance cancer care. The booming economy and rapidly growing middle-class population in the nation have resulted in huge investments in adopting advanced healthcare technologies. Moreover, the motivation for the achievement of self-sufficiency in the production of medical equipment with strong indigenous capabilities is to reduce the dependence on imports. Strong public-private partnerships are making it easy to establish advanced treatment centers. Also, the increasing awareness of screening and early cancer detection further results in rising demand for radiotherapy services. The country's aspirations to position itself as a global healthcare hub create the need to equip the country with advanced radiotherapy equipment, which would prove indispensable in supplying quality cancer care and placing the country competitively in the international market.

Furthermore, the expansion of healthcare centers, such as specialized centers of cancer and radiation therapy facilities, enhances the availability and accessibility of radiotherapy equipment. For instance, in April 2024, Lady Hardinge Medical College, located in New Delhi, inaugurated and treated its first cancer patient with brachytherapy equipment. This treatment is provided for patients suffering from some kinds of cancers and other diseases. With more facilities being set up, this will increase accessibility to radiotherapy services, hence increasing the demand for radiotherapy devices in further treatment of patients.

Increasing Cancer Burden Influencing India Radiotherapy Devices Market Growth

The rising burden of cancer cases in India is resulting in a higher demand for radiotherapy devices, which, in turn, leads to the expansion of the radiotherapy devices market. The alarming increase in cancer cases in India, which gets worsened by significantly delayed diagnoses resulting in higher mortality rates along with lower recoveries, necessitates raising public awareness and educational awareness among professionals to address this significant issue. Predictive and precision medicine, and integrated AI diagnostics, provide further hope to tackle this issue. The demand for radiotherapy devices is expected to significantly increase as diagnostic methods become more common and affordable. Increasingly systematic screening programs focusing on prevalent cancers, as well as on high-risk individuals, are essential. Risk identification and improvement of data sharing constitute part of the government's digital health initiatives. Collaboration between the public and private sectors is of utmost importance in adequately dealing with the growing burden of cancer. Such interaction will promote demand for better-advanced radiotherapy technologies that improve patient care and outcomes. Public-Private Partnerships (PPPs) have significantly increased access to cancer care in India. For example, Varian Medical Systems, Inc. has partnered with the Central and State Governments to establish radiation therapy centers in public hospitals. The government provides the infrastructure, while private operators supply the equipment and services at agreed-upon prices for the benefit of patients.

Increasing Government Initiatives to Drive the Radiotherapy Devices Market Growth

The government has initiated various schemes and policies to encourage growth in the medical devices market, particularly radiotherapy equipment. The Make in India initiative supports the domestic manufacturing of medical devices, including those used in cancer treatment, to reduce import dependency. Moreover, in the Production Linked Incentive Scheme (PLI) scheme, incentives are proposed for specific cancer care technologies, including advanced radiotherapy technologies.

Such developments allow growth and innovation for the medical industry in India, which, in turn, attracts investments that help research institutions develop technology to increase the adoption of advanced medical devices in health facilities. In this case, with growing awareness about treatments for cancer treatment, more patients will look at the need for advanced therapies, increasing device demand and promoting the Indian radiotherapy devices market progression. For instance, in June 2024, Apollo Cancer Centres partnered with Accuray Medical Equipment India Pvt. Ltd., to introduce India's first Robotic Stereotactic Radiotherapy Program. It will provide advanced training for radiation oncologists, physicists, and technicians in Chennai and Bangalore locations. This program will feature hands-on training and in-depth discussions to enhance local medical education, providing improved cancer care using the Cyberknife system.

Developments in Technology to Propel India Radiotherapy Devices Market Growth

With the increase in cancer cases, there is an emerging demand for advanced technologies in treatment, especially among late-stage cancers that are challenging to treat. The rise in cancer cases in India highlights the market for an advanced and affordable healthcare system covering cancer care so that anyone can easily approach cancer care. Innovations in radiotherapy from key players in the healthcare sector are involved in improving comfort for cancer patients. Many hospitals and medical facilities have embraced these innovations. Advanced treatment techniques used include proton therapy, precision radiation therapies such as intensity-modulated radiation therapy, and image-guided radiation therapy. For instance, in August 2024, Sahyadri Hospitals Private Limited installed the TomoTherapy Radixact X9 system with VitalHold technology. This radiotherapy solution has unfolded new dimensions in treating cancer by providing precision, significantly when tumors are affected by patient movement. It is the first installation in Asia with the system and features Auto Beam Hold, which will cease radiation if the patient moves beyond safe limits. Advanced imaging capabilities significantly improve the detection and accuracy of treatment in tumors, hence elevating patient care.

Hospitals to Hold Substantial Market Share

Hospitals in India account for a relatively more significant share of the radiotherapy devices market due to the increasing patient requirements for cancer treatment, technological advancements, and government initiatives towards healthcare infrastructure development. Their capability to provide comprehensive care invests in modern equipment that enhances the quality of service delivered. This trend accelerates market growth, attracts further investments in innovations, and brings about healthy competition among the manufacturers, which results in better accessibility and affordability of radiotherapy services amongst patients located in various parts of the country. Therefore, hospitals are increasingly installing such advanced radiotherapy devices in their facility to improve patient outcomes. For instance, in April 2024, the Swami Rama Himalayan University (SRHU) Cancer Research Institute (Himalayan Hospital) installed the Halcyon B Linear Accelerator for radiotherapy at the Himalayan Hospital. With cancer cases on a leap and bound in India, this high-end machine will enhance the present treatment portfolio of the patients. Being the first private teaching hospital in Uttarakhand wielding this technology, Himalayan Hospital would ensure the pain of the side effects among its affected patients is not so grueling during treatment and, hence, bring a highly positive change.

Future Market Scenario (FY2025 -FY2032F)

Technologically advanced elements, such as precision radiation therapy, integration of AI for treatment planning, and new technologies like proton therapy, will drive the Indian market for radiotherapy devices. Major companies are stressing cost-effective solutions and are enhancing patient care through personalized treatment approaches. In September 2024, Accuray Medical Equipment India Pvt. Ltd (Accuray) unveiled its CE-marked Accuray Helix system in India. The CT-guided helical radiotherapy system will provide high performance and efficiency, reaching into emerging markets where advanced cancer care, including radiotherapy is often limited to urban areas with fewer facilities such as a linear accelerator.

Key Players Landscape and Outlook

Major players in India radiotherapy devices market are building their presence through partnerships with government hospitals, increasing the distribution outreach, and investing in local manufacturing. It includes improving access to best-in-class cancer treatment and resultant gains to strengthen their competitive position in the market.

In November 2023, Elekta AB (Elekta) received an order worth USD 40 million from Krishna Institute of Medical Sciences (KIMS) in Hyderabad. The order includes cutting-edge equipment like the Elekta Unity MR-Linacs and Leksell Gamma Knife systems, which will enable KIMS to deliver more personalized cancer treatments and enhance the care of their patients while minimizing side effects.

In July 2023, Elekta AB (Elekta) collaborated with GE HealthCare Technologies Inc., intending to scale up accessibility to precise radiation therapy in India. Through this agreement, these companies will ensure that complete systems for imaging and treatment are delivered to hospitals, providing radiation therapy to cancer patients and, hence, improving the care of patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Radiotherapy Devices Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. External Beam Radiation Therapy Devices
      • 4.2.1.1.1. Advanced Linear Accelerators
        • 4.2.1.1.1.1. Gamma Knife
        • 4.2.1.1.1.2. Cyberknife
        • 4.2.1.1.1.3. TomoTherapy
        • 4.2.1.1.1.4. MRI LINAC
      • 4.2.1.1.2. Conventional Linear Accelerators
      • 4.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
      • 4.2.1.1.4. Proton Therapy Devices
        • 4.2.1.1.4.1. Cyclotrons
        • 4.2.1.1.4.2. Synchrotron
        • 4.2.1.1.4.3. Synchrocyclotron
    • 4.2.1.2. Internal Beam Radiation Therapy Devices
      • 4.2.1.2.1. Brachytherapy Devices
      • 4.2.1.2.2. Consumables
    • 4.2.1.3. Others
  • 4.2.2. By Application
    • 4.2.2.1. Lung Cancer
    • 4.2.2.2. Breast Cancer
    • 4.2.2.3. Prostate Cancer
    • 4.2.2.4. Head and Neck Cancer
    • 4.2.2.5. Other Applications
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Ambulatory Surgical Centers
    • 4.2.3.3. Cancer Care Centers
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West and Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 5 Market Players
  • 16.3.1. Elekta Medical Systems India Pvt. Ltd.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. Accuray Medical Equipment India Pvt. Ltd.
  • 16.3.3. Koninklijke Philips N.V.
  • 16.3.4. Ion Beam Applications S.A.
  • 16.3.5. Vision RT Ltd.
  • 16.3.6. BEBIG Medical GmbH
  • 16.3.7. Mitsubishi Electric India Pvt. Ltd.
  • 16.3.8. Varian Medical Systems, Inc.
  • 16.3.9. Society for Applied Microwave Electronics Engineering & Research
  • 16.3.10. Brainlab India Pvt. Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer